<DOC>
	<DOCNO>NCT01216501</DOCNO>
	<brief_summary>In child , radiofrequency catheter ablation ( RFCA ) cryoablation highly effective treatment supraventricular tachycardia treatment . General anesthesia often required ensure comfort prolonged procedure assure immobility order facilitate accurate mapping subsequent ablation accessory pathway and/or arrhythmogenic focus . Successful anesthetic management patient population require adequate suppression sympathetic response procedure electrophysiological parameter remain unaltered mapping purpose subsequent ablation . Although Sevoflurane ( SEVO ) Isoflurane ( ISO ) two commonly use evaluate volatile anesthetic agent ablation procedure , comparison agent perform previously adult , child . Hypothesis Time require basic EP interval , successful induction SVT successful RFCA cryoablation child different patient undergo Sevoflurane Isoflurane-based anesthesia .</brief_summary>
	<brief_title>Sevoflurane Isoflurane RF Cryo Ablation Children .</brief_title>
	<detailed_description>In child , radiofrequency catheter ablation ( RFCA ) cryoablation highly effective treatment supraventricular tachycardia treatment . General anesthesia often required ensure comfort prolonged procedure assure immobility order facilitate accurate mapping subsequent ablation accessory pathway and/or arrhythmogenic focus . Successful anesthetic management patient population require adequate suppression sympathetic response procedure electrophysiological parameter remain unaltered mapping purpose subsequent ablation . Although Sevoflurane ( SEVO ) Isoflurane ( ISO ) two commonly use evaluate volatile anesthetic agent ablation procedure , comparison agent perform previously adult , child . Hypothesis Time require basic EP interval , successful induction SVT successful RFCA cryoablation child different patient undergo Sevoflurane Isoflurane-based anesthesia . Patients The study group include otherwise 200 lthy patient age 4 18 year , ASA physical status I II , schedule elective radiofrequency ablation cryoablation interrupt abnormal focus and/or accessory pathway Schneider Children 's Medical Center Israel ( SCMCI ) . Written inform consent obtain patient ( age 12 ) , parent ( ) legal guardian participant . Duration study- 2 year . Inclusion criterion : healthy patient age 4 18 year , ASA physical status I II , schedule elective radiofrequency ablation cryoablation treat SVT . Exclusion criterion : patient accompany cardiac defect disease , suspect Malignant Hyperthermia , contraindication volatile anesthetic use patients/ parental refusal . Anesthesia The investigator use standard anesthesia protocol . Routine monitoring include electrocardiography , noninvasive blood pressure measurement , capnography pulse oximetry . The patient randomly divide two group accord last digit 9-digit identification number : patient odd number allocate Sevoflurane ( SEVO group ) patient even number allocate Isoflurane ( ISO group ) . Preanesthetic medication consist midazolam give either orally ( 0.5 mg/kg maximum 10 mg ) intravenously ( 2.0 mg ) intravenous ( IV ) access establish induction anesthesia . Anesthesia induce either via facemask Sevoflurane ( Abbot Laboratories Ltd. , UK ) 66 % nitrous oxide 33 % oxygen IV Propofol ( Diprivan , B Braun , Germany ) 2.5 mg/kg . In patient undergo mask induction intravenous line establish lose consciousness , Sevoflurane discontinue Propofol ( 2.5 mg/kg ) administerd IV . Before tracheal intubation lung preoxigenated 100 % O2 . Pancuronium ( 0.1 mg/kg ) Fentanyl ( 2-4 µg/kg ) use facilitate tracheal intubation . After tracheal intubation , fresh gas flow set 1 l/min O2 1 l/min room air remainder procedure . Thereafter , anesthesia maintain assign study drug ( SEVO ISO ) oxygen/air 50 % mixture . In ISO group , Isoflurane start inspiratory fraction 1MAC SEVO group Sevoflurane start inspiratory fraction 1MAC adjust age . Pancuronium use neuromuscular drug intraoperative period , need . After induction anesthesia , standard baseline program stimulation electrophysiological protocol perform use transvenous endocardial electrode allow calculate follow parameter : right atrial refractory period , atrioventricular node effective refractory period , accessory pathway effective refractory period , right ventricular effective refractory period . Decremental pace right atrium ventricle allow determine short cycle length antegrade retrograde conduction , also call `` Wenckebach cycle length , '' 1:1 conduction normal atrioventricular node accessory pathway . Right atrial ventricular extrastimulus test involves pace standard drive cycle length 200 , 400 600 m , follow extrastimulus couple ( step 20 ms 600-300 m step 10 m less 300 m ) every eighth drive beat . Baseline interval measure sinus rhythm include intraatrial conduction time ( PA interval ) , atrial-His interval . During induced reciprocate tachycardia , conduction time component reentrant circuit measure included cycle length atrial-His , His-ventricular , ventriculoatrial interval . All electrophysiological measurement record use standard digitize tablet paper speed 100 mm/s . Programmed stimulation perform use Mennen stimulator , data display , record , analyze use standard computerize multichannel system . If clinically suspect SVT induced baseline protocol , isoproterenol ( 0.03-0.07 µg • kg- 1 • min-1 ) infuse , protocol repeat SVT induce . After conclusion diagnostic study , ablation abnormal substrate ( ) perform use commercial radiofrequency generator ( ATKAR ) . If need , muscle relaxation reestablish use pancuronium 0.05mg/kg allow ablation perform apnea avoid respiration-related intrathoracic movement . This approach permit application radiofrequency energy near vital structure , atrioventricular node , reduce concern potentially dangerous catheter dislodgement . The final diagnostic electrophysiological study repeat baseline isoproterenol ( 0.03-0.07 µg • kg- 1 • min- 1 ) . Extubation perform patient awake . Post procedural care provide recovery room , patient transfer ward hemodynamically stable , fully conscious able protect airway , without pain severe nausea active vomiting . Time Analyses The following time interval analyze : Onset SVT time - T1 ( start first diagnostic electrophysiological study induction first SVT ) ; Diagnostic electrophysiological study time - T2 ( start first diagnostic electrophysiological study start ablation ) ; RFCA/ cryoablation procedure time - T3 ( start first diagnostic electrophysiological study end final diagnostic electrophysiological study ) ; Wake-up time - T4 ( end wound dress patient exit operate room post-anesthesia care unit ) ; Total anesthesia time -T5 ( patient entry operate room exit operate room ) . If patient enter laboratory SVT SVT induce initial catheter placement , `` onset SVT time '' designate `` 0 min . '' Additionally , investigator compare antegrade effective refractory period accessory pathway ( antegrade APERP ) , ventricular effective refractory period ( VERP ) , atrial effective refractory period ( AERP ) , AH interval , cycle length circus movement tachycardia ( CMT-CL ) . In addition , investigator compare incidence postoperative nausea vomiting ( PONV ) group patient procedure ( globally patient , need Transesophageal Echocardiography - TEE ) . In case PONV , Ondansetron ( Zofran ) order dose 0.1mg/kg IV . If PONV continue ondansetron administration , second dose drug give dose 0.1 mg/kg . The electrophysiologist , performs procedure , patient parent blind randomization status . Time point period record nurse , blind randomization status . The incidence PONV record nurse post anesthesia care unit ( PACU ) , blind randomization status .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>healthy patient age 4 18 year , ASA physical status I II , schedule elective radiofrequency ablation cryoablation treat SVT . patient accompany cardiac defect disease , suspect Malignant Hyperthermia , contraindication volatile anesthetic use patients/ parental refusal .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>